Triferic (Ropack Inc.)
Welcome to the PulseAid listing for the Triferic drug offered from Ropack Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ropack Inc. |
NON-PROPRIETARY NAME: | FERRIC PYROPHOSPHATE CITRATE |
SUBSTANCE NAME: | FERRIC PYROPHOSPHATE CITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | PARENTERAL |
DOSAGE FORM: | POWDER |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-11-28 |
END MARKETING DATE: | 0000-00-00 |
Triferic HUMAN PRESCRIPTION DRUG Details:
Item Description | Triferic from Ropack Inc. |
LABELER NAME: | Ropack Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 272(mg/272mg) |
START MARKETING DATE: | 2016-11-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64811-315_425df869-79f6-481b-e054-00144ff88e88 |
PRODUCT NDC: | 64811-315 |
APPLICATION NUMBER: | NDA208551 |
Other FERRIC PYROPHOSPHATE CITRATE Pharmaceutical Manufacturers / Labelers: